Author: Tresia Bowles / Source: wsaz.com
(KPLC/Gray News) – Two more hypertension medications have been recalled due to a possible process impurity or contaminant in an active pharmaceutical ingredient, according to the FDA.
Legacy Pharmaceutical Packaging LLC.
is recalling 40 lots of Losartan Potassium Tablets, USP, 25 mg, 50 mg and 100 mg, as well as three repackaged lots of Losartan Potassium Tablets, USP, 50 mg due the detection of trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA), says the FDA. NMBA is a potential human carcinogen.…
The post More lots of blood pressure medications recalled due to impurity appeared first on FeedBox.